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ABSTRACT 
Laminitis is a common, debilitating condition of equids that may have 
substantial effects on animal welfare. Laminitis is not a disease, but a sign 
which may be related to endocrinopathic or inflammatory diseases, as well as 
uneven weight distribution. Until recently, research into the prevalence of 
endocrine disease amongst horses with laminitis has been overlooked, 
although it was anecdotally thought to be high. Most histological studies have 
been conducted on experimental carbohydrate overload or inflammatory 
models. However, more recently the histology of a hyperinsulinaemic model 
of laminitis was described with important differences apparent from the 
previous inflammatory models – however, a more detailed study had not been 
performed. Furthermore, the histology of chronic, naturally occurring 
endocrinopathic laminitis has not been described and compared to that of 
healthy animals.  
The research presented in this thesis aimed to investigate laminitis 
unassociated with systemic illness or gastrointestinal disease, i.e. presenting 
primarily as lameness (primary laminitis). Specifically, we hypothesized that 
endocrine disturbances were the most common cause for primary laminitis. In 
addition, we aimed to provide new information on the histological appearance 
of experimentally induced hyperinsulinemic laminitis. Specifically, our aim 
was to describe the cellular changes behind the key lesion of laminitis, lamellar 
elongation. Lastly, the most important aim of this thesis was to describe the 
histology of naturally occurring endocrinopathic laminitis. 
In Study I, the prevalence of endocrine disease among 36 horses that 
presented for laminitis at Helsinki University Equine Teaching Hospital was 
determined using endocrine tests and phenotypic indicators. Evidence of an 
endocrinopathy (either basal hyperinsulinemia or pituitary pars intermedia 
dysfunction, PPID) was present in 89% of cases. 
       In Study II, four healthy ponies were exposed to prolonged 
hyperinsulinemia while maintaining euglycemia - the cellular changes 
associated with secondary epidermal lamellae (SEL) in that experimentally 
induced hyperinsulinemic laminitis model were evaluated. The SEL 
elongation, narrowing and alteration in orientation were largely attributable 
to cell stretching (rather than proliferation as had been hypothesised), that 
occurred at the same time as an accelerated cell death-proliferation cycle. 
In Study III, the histomorphometry and (macroscopic and microscopic) 
pathological lesions of endocrinopathic laminitis were described in 14 animals 
with hyperinsulinemia, with reference to age- and breed-matched controls. 
Lesions were largely localized abaxially within the lamellar tissue and included 
increased lamellar length and width, chronic abnormal keratinization, 
interlamellar epidermal bridging and apoptotic cell death with more acute 
lamellar tearing in some cases. Axially, epidermal lamellar tapering was the 
most frequent morphological observation. Additionally, in all the laminitis 
cases, there were macroscopic pathological changes (divergent rings on the 
outer hoof wall and/or gross separation and rotation of distal phalanx). 
However, both microscopic and macroscopic pathology varied in severity and 
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were unrelated to the reported duration of laminitis. 
In Study IV, using 16 animals diagnosed with PPID, the endocrine status, 
histomorphometry and pathological lesions of those with laminitis (n=10) and 
those without (n=6) were compared. All the laminitic PPID animals also had 
hyperinsulinemia whereas all of the non-laminitic PPID animals were 
normoinsulinemic. In addition, all the animals with PPID and laminitis had 
histological lesions in the lamellar region, but the lamellae of PPID animals 
without laminitis were normal when compared to the control group. 
In conclusion, endocrinopathic laminitis is by far the most common type 
of naturally occurring laminitis in horses and hyperinsulinemia is likely to be 
the primary cause in those horses, including those with PPID. In the acute 
phase, the pathophysiology behind the key lesion, SEL elongation, is proposed 
to be cellular (mechanical) compromise resulting in epidermal cellular 
stretching. In the chronic phase, the lamellar lesions are variable in severity in 
many cases allowing for a prolonged subclinical phase, and they are located 
predominantly abaxially close to the hoof wall. 
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1 INTRODUCTION 
Laminitis, defined as an “inflammation” of the hoof lamellar region, is a 
common debilitating condition of equids.  However, while the suffix ‘itis’ refers 
to inflammation, it is not the primary mechanism of all types of laminitis, and, 
as found in this research, is not the primary lesion in endocrinopathic 
laminitis. Irrespective of the mechanism, in laminitis the hoof lamellar 
structures weaken, which may lead to mechanical failure of the suspensory 
apparatus of the distal phalanx (DP) and compromise the normal 
biomechanical function of the hoof during weight bearing. This results in foot 
pain with associated stance and gait alterations. Laminitis usually affects all 4 
feet, although the clinical signs are often more pronounced in the fore feet. The 
signs vary from mild lameness to a complete inability to move. The degree of 
pain, poor prognosis and frequency of recurrence make this condition 
important from both the economic and animal welfare points of view (Hunt 
1993, Pollitt 2004, Collins et al. 2010). 
Laminitis is not a disease, but rather a clinical sign, yet for decades 
laminitis has been considered to be an independent disease entity. The 
inflammatory form of laminitis secondary to systemic infection (e.g. colitis, 
metritis or pleuropneumonia) was incorrectly assumed to be the most 
common form of laminitis because it was more commonly seen at the 
University hospitals where most of the laminitis studies had been conducted– 
and where horses with systemic inflammatory disease were more likely to be 
referred. Obel (1948) used both naturally occurring metritis (retained 
placenta) and experimental starch overload models in his original research. 
More recently laminitis was mostly studied using the inflammatory models of 
black walnut or starch/oligofructose overload (Garner 1975, Galey 1991, van 
Eps and Pollitt 2006). Systemic endocrine disease (insulin resistance or 
intolerance) was known to be clearly associated with laminitis but received 
relatively little attention (Coffman and Colles 1983, Jeffcott et al. 1986). This 
was most likely due to the incorrect assumption that pasture-associated 
laminitis was also a form of carbohydrate (CHO) overload (Longland and Byrd 
2006, van Eps and Pollitt 2006, Kalck et al. 2009) and also the lack of 
appropriate epidemiological analysis of laminitis cases in general clinical 
populations, with studies till 2012 not involving investigation of cause (Wylie 
et al. 2012).  In 2007, a new model of insulin-induced laminitis was described 
and this changed general thinking about laminitis remarkably. All the animals 
(ponies) exposed to prolonged hyperinsulinemia while maintaining 
euglycemia, developed laminitis in approximately 48 hours.  Importantly, 
none of the animals became systemically ill or showed gastrointestinal 
disturbance during the induction of laminitis (Asplin et al. 2007). This 
hyperinsulinemic model much more closely resembled the naturally occurring 
clinical picture of pasture-associated laminitis, yet had been overlooked as 
important in the CHO overload models (van Eps and Pollitt 2006, Kalck et al. 
2009). 
In the very first studies on the histology of laminitis, the primary 
pathological changes were assumed to be located in the vascular tissues due to 
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the prominent clinical signs of bounding digital pulses and heat in the hoof 
(Gutenäcker 1899, Eberlein 1908, Möller 1920, Åkerblom 1934, Cohrs 1941). 
However, in 1948 Obel overturned this theory and showed that most of the 
lesions were epithelial, i.e. in the lamellae (Obel 1948). Later basement 
membrane (BM) pathology was claimed to be the key lesion in laminitis based 
on examination of specimens from three horses that developed laminitis 
following starch overload (inflammatory laminitis; Pollitt 1996). However, BM 
pathology has not been a consistent finding in all the inflammatory studies, 
nor has it been consistent in animals with experimental hyperinsulinemic 
laminitis (Morgan et al. 2003, Asplin et al. 2010, de Laat et al. 2011a). 
Elongation of the secondary epidermal lamellae (SEL) (together with 
increased mitotic activity and apoptosis) has been shown to be the key 
histological lesion of insulin induced laminitis (Asplin et al. 2010, de Laat et 
al. 2011a), but the induction models may not represent the naturally occurring 
cases very well. This is in part due to the fact that spontaneous 
(endocrinopathic) laminitis is seldom genuinely acute but has frequently been 
developing for months or even years (as compared with inflammatory 
laminitis which is often/always acute). However, there are few studies 
concerned with the histology of naturally occurring laminitis and many of 
them lack adequate clinical details of the sampled horses to indicate the 
underlying pathogenesis and, therefore, to correlate it with histological lesions 
(Roberts 1980, Kuwano et al. 2002, Kuwano et al. 2005, Hampson et al. 2012). 
Additionally, some studies have used horses exposed to different or several 
etiologies (endocrinopathic, inflammatory, mechanical) and should therefore 
be interpreted carefully (Carter et al. 2011, Engiles et al. 2015). 
The research presented in this thesis aimed to investigate laminitis not 
associated with systemic illness or gastrointestinal disease, i.e. presenting 
primarily as lameness (primary laminitis). Specifically, we hypothesized that 
endocrine disturbances would be the most common cause for primary 
laminitis. In addition, we aimed to provide new information about the 
microscopic and macroscopic lesion involved in experimentally induced 
hyperinsulinemic laminitis. Specifically, our aim was to describe the cellular 
changes behind the key lesion of laminitis, lamellar elongation. Lastly, the 
most important aim of this thesis was to describe the histological lesions in 
naturally occurring endocrinopathic laminitis and to determine any 
relationship to lesions seen in the (acute) experimental models. 
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2 REVIEW OF THE LITERATURE 
2.1 Laminitis 
Laminitis is a common, crippling and often life threatening condition of 
Equidae which has been shown to account for up to 15% of all lameness cases 
in the equine population (USDA 2000). Historically laminitis has been 
considered to be an inflammation of the hoof lamellar region, therefore the 
name laminitis. The clinical signs include lameness involving one or multiple 
hooves, stiffness, weight shifting, a typical ‘saw horse’ stance (Figure 1) and a 
reluctance to move. Additional signs include increased digital arterial pulses 
and sensitivity to hoof tester pressure applied at the toe of the affected digit/s 
(Dyson 2011). Many horses with laminitis also present with gross hoof wall 
alterations including divergent rings (outer hoof wall horizontal lines that are 
wider at the heel than the toe, Figure 2), the presence of excessive cap horn 
(arcade-like keratin formation over the primary dermal lamellae abaxially) or 
a wider/separated white line, and flat or convex soles (Pollitt 2004, Collins et 
al. 2010). These gross changes have typically been considered to be associated 
with previous clinical episodes of laminitis or prolonged chronic laminitis 
(Pollitt 2004, Eustace 2010).  
Diagnosis of laminitis can be made based on typical clinical signs, but 
diagnostic imaging (e.g. radiography or magnetic resonance imaging) is often 
used to confirm evidence of lamellar disruption including sinking or rotation 
of the DP, especially in chronic cases with structural changes (e.g. lamellar 
radiolucency or bone remodeling of the DP) (Figure 3; Murray et al. 2003, 
Hunt et al. 2010). Other techniques such as venograms have indicated 
disruption to the blood flow of the hoof (D’Arpe et al. 2010), but imaging using 
some of the newer emerging technologies such as 3-D and 4-D 
ultrasonography and imaging real-time blood flow are limited due to the hoof 
wall attenuating sound (Sage et al. 2002). 
The severity of laminitis varies between animals and the phase of the 
disease. The severity of pain can be evaluated by using the Obel scale. Grade 
0 horses are sound. Grade 1 horses shift weight, but lameness (stilted gait) is 
only noticeable at trot, whereas Grade 2 horses are lame at walk. Grade 3 
horses move reluctantly and resist attempts to lift a hoof. Grade 4 horses are 
often recumbent, but if standing, they will not move unless forced to do so 
(Obel 1948). 
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Figure 1. A laminitic Shetland pony with typical saw horse stance. Note the general obesity 
indicative of equine metabolic syndrome. 
 
 
 
 
Figure 2. Divergent rings on the outer hoof wall of a laminitic pony. 
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2.2 Causes of laminitis 
Laminitis usually occurs in association with systemic disease or endocrine 
dysfunction. Less frequently it may be the result of uneven mechanical 
loading, for example due to lameness in the contralateral limb (support limb 
laminitis, SLL). Systemic diseases associated with laminitis are either 
endocrinopathic dysfunction or severe inflammatory conditions (e.g. colitis, 
metritis or pleuropneumonia). The latter are associated with severe systemic 
clinical signs such as alterations in demeanor, leucocyte count, pyrexia and 
diarrhea. Hence this type of laminitis can be termed inflammatory laminitis. 
Endocrinopathic dysfunction (e.g. hyperinsulinemia or pituitary pars 
intermedia dysfunction, PPID) is typically associated with fewer clinical signs 
(e.g. hypertrichosis, weight redistribution and obesity) and often presents 
primarily as lameness due to laminitis. This type of laminitis can be termed 
endocrinopathic laminitis. Inflammatory and support limb laminitis are 
discussed only briefly since they are not the objective of this dissertation. 
2.2.1 Inflammatory laminitis 
Historical ‘classical laminitis’, was associated with severe inflammatory 
conditions (inflammatory laminitis). In the time of Obel’s research (Obel 1948) 
inflammatory laminitis was probably the most common type of laminitis, since 
inflammatory conditions like post parturient metritis or colitis due to excessive 
amounts of grain were not as treatable as nowadays. Endocrinopathic diseases 
were less common since horses were lean and exercised regularly. In addition, 
horses did not live long enough for PPID to be a common etiological factor.  
Horses with inflammatory laminitis are systemically ill (Parsons et al. 
2007). These animals often have systemic inflammatory response syndrome 
(SIRS), which is manifested by two or more of the following variables: 
hypothermia or fever, tachycardia, tachypnea and an abnormal leukocyte 
count (American College of Chest Physicians/Society of Critical Care Medicine 
1992). Horses with CHO - or black walnut extract (BWE) -induced 
inflammatory laminitis have been shown to have systemic signs of 
inflammation including depression, anorexia (Galey et al. 1991), diarrhea and 
fever (van Eps and Pollitt 2006). Laminitis has been shown to occur secondary 
to systemic inflammation and is usually acute and severe compared to animals 
with endocrinopathic laminitis. There is up-regulation of multiple 
inflammatory pathways (Noschka et al. 2009) and vascular dysfunction 
(Robertson et al. 2009); however, the precise pathophysiology of 
inflammatory laminitis has not been fully elucidated (Katz et al. 2012). The 
role of endotoxemia due to excessive amounts of carbohydrates in the hindgut, 
subsequent changes in bacterial population, drop in pH and degeneration of 
the cecal lining have been shown to contribute to the pathophysiology of 
inflammatory laminitis (Garner et al. 1978, Moore et al. 1979). However, 
lipopolysaccharides (LPS; endotoxins) did not induce laminitis when 
administered alone to healthy horses (Tóth et al. 2009). When LPS were given 
in conjunction with oligofructose, most of the horses developed laminitis (Tóth 
et al. 2009). Therefore, it may be suggested that endotoxins play a role in the 
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development of laminitis but they are not the only causative factors. In fact, 
insulin sensitivity decreased after oligofructose administration and, therefore, 
it is possible that insulin dysregulation also has a role in CHO induced 
laminitis (Tóth et al. 2009). However, in hospital settings clinical signs of 
endotoxemia have been shown to be the most significant risk factor in 
multivariate analysis for the development of laminitis (Parsons et al. 2007).  
Inflammatory laminitis has been studied by using either CHO overload 
(starch or oligofructose) or the BWE models (Åkerblom 1934, Obel 1948, 
Garner et al. 1975, Minnick et al. 1987, Galey et al. 1991, Pollitt 1996, van Eps 
& Pollitt 2006). In these models, systemic signs, like fever and leukopenia or 
leukocytosis and diarrhea (only in CHO overload models) occur first and 
laminitis develops secondarily - on this basis, the models represent natural 
inflammatory cases reasonably well (Garner et al. 1975, Minnick et al. 1987, 
Galey et al. 1991, van Eps and Pollitt 2006, Loftus et al. 2007). Laminitis 
occurs in BWE models slightly earlier (8-12 h post induction) than in CHO 
overload models (20-44 h post induction); however, even though the majority 
of animals develop laminitis in these models, there are also individuals that do 
not (Minnick et al. 1987, Pollitt 1996, Morgan et al. 2003, van Eps and Pollitt 
2006) supporting the idea that there may be multiple contributory factors in 
these forms of laminitis. 
2.2.2 Support limb laminitis 
Support limb laminitis (SLL) is a relatively rare condition that occurs as a 
sequel of painful limb conditions including catastrophic fracture or infective 
bone or synovial processes. SLL occurs due to excessive unilateral weight 
bearing in the contralateral limb and is often a devastating condition (Baxter 
and Morrison 2009, van Eps et al. 2010, Virgin et al. 2011, Wylie et al. 2015). 
In a recent study the prevalence of SLL in a large equine practice in UK was 
0.02% and young or middle-aged (median 6 years) Thoroughbreds were most 
commonly affected (Wylie et al. 2015). However, among horses treated with 
half limb, full limb or transfixation pin casts, the prevalence was 12%. Greater 
bodyweight and duration of casting were shown to be risk factors for SLL, but 
not the severity of the orthopedic condition (Virgin et al. 2011). In a third study 
only the duration of lameness, not the body weight was associated with SLL 
and mortality among those animals was high (Peloso et al. 1996).  
The exact pathophysiology of SLL is unknown but according to van Eps et 
al. (2010) there are two possible theories: either SLL occurs directly due to 
mechanical overload or it is a sequel of hypoperfusion due to the lack of cyclic 
loading and unloading of the foot (van Eps et al. 2010). However, more 
research regarding the pathophysiology of SLL is warranted. 
2.2.3 Endocrinopathic laminitis 
The major endocrinopathic disorders resulting in laminitis are equine 
metabolic syndrome (EMS) and/or pituitary pars intermedia dysfunction 
(PPID). In addition, iatrogenic glucocorticoid administration has been 
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associated with laminitis (McGowan 2010). Unlike inflammatory laminitis, 
endocrinopathic laminitis is seldom (if ever) acute but usually rather develops 
for months or years before the first clinical signs (Walsh 2010). In addition, 
inflammation is not a major factor of endocrinopathic laminitis and the 
animals are not systemically ill (Asplin et al. 2007, de Laat et al. 2010). 
EMS is mainly a disease of young to middle-aged horses characterized by 
obesity, insulin resistance or dysregulation and laminitis (Frank et al. 2010; 
Frank and Tadros 2014). In addition, hyperleptinemia (Cartmill et al. 2003), 
hypertriglyceridemia (Treiber et al. 2006, Carter et al. 2009, Frank et al. 
2006), arterial hypertension (Carter et al. 2009, Bailey et al. 2008), altered 
reproductive cycling in mares (Gentry et al. 2002, Vick et al. 2006) and 
increase in certain markers of inflammation related to obesity (Vick et al. 
2007) may be evident in some animals. The diagnosis of EMS can be made 
based on phenotypic indicators (general or regional obesity, Figure 1) and 
disturbed insulin and glucose regulation. Insulin and glucose dysregulation 
can be evaluated either by measuring basal serum insulin concentration and 
detecting hyperinsulinemia, or using dynamic tests like the oral sugar test or 
combined glucose-insulin tolerance test (Frank et al. 2010). EMS can also 
affect older horses, especially those with PPID. In fact, age has been shown to 
be a risk factor for EMS in an epidemiological investigation of 
hyperinsulinemia in ponies (Morgan et al. 2014). 
PPID is a disease of aged horses characterized by loss of dopaminergic 
inhibition of the pituitary pars intermedia and resultant overproduction of 
pituitary hormones: adrenocorticotropin (ACTH), α-melanosyte-stimulating 
hormone (α-MSH), corticotropin-like intermediate peptide (CLIP) and β-
endorphin. The clinical signs include hypertrichosis (Figure 4) and abnormal 
shedding patterns, muscle wastage, abnormal fat distribution, laminitis, 
polyuria and polydipsia, increased susceptibility to infections, sweating and 
infertility (McFarlane 2011). PPID is diagnosed by using phenotypic indicators 
and diagnostic testing.  Commonly used diagnostic tests are the measurement 
of basal plasma ACTH concentration and the overnight dexamethasone 
suppression test (ODST) (McFarlane 2011). Since pituitary hormones have 
natural circannual variation, seasonally adjusted reference ranges are used for 
basal plasma ACTH (Copas and Durham 2012), with increased sensitivity and 
specificity in late summer and autumn (McGowan et al. 2013). The ODST has 
low specificity during the autumn months and should therefore not be used 
from August to October (Durham et al. 2014). In addition to ante mortem 
tests, PPID can be diagnosed on the basis of pituitary pathology (hyperplasia, 
microadenomas or macroadenoma) post mortem, although lower grade 
lesions (hyperplasia and microadenomas) are not always specific for PPID 
(Miller et al. 2008). 
Iatrogenic glucocorticoids have been shown to induce hyperinsulinemia 
and insulin resistance (French et al. 2000, Tiley et al. 2008) and therefore 
corticosteroid administration carries a risk of laminitis. Although iatrogenic 
laminitis has been shown to be relatively rare (McCluskey et al. 2004, Bathe 
2007, Cornelisse et al. 2013), careful consideration should be used when 
glucocorticoids are administered to animals with a suspicion of an underlying 
endocrinopathy (obesity, long hair coat etc.), previous laminitis or current 
systemic inflammation (McGowan et al. 2016). 
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Figure 4. An aged pony with pituitary pars intermedia dysfunction in the Finnish summer (A) 
and winter (B). Note the long haircoat independent of season (hirsutism) and delayed or lack 
of shedding of the hair in summer. 
 
2.3 Insulin dysregulation and laminitis 
Insulin is a peptide hormone secreted by pancreatic beta cells. It is the major 
regulatory hormone in glucose (and fat) metabolism and the secretion is 
mainly regulated by the plasma glucose concentration. Compensatory 
hyperinsulinemia develops when there is a state of insulin resistance (the 
inability of cells to respond to insulin) in target cells and this can be detected 
basally, or as an abnormal response to dynamic glucose challenge.  
The first implications of insulin resistance in the pathogenesis of laminitis 
were from the 1980s when glucose intolerance and reduced insulin sensitivity 
were noticed in ponies that had previously experienced laminitis compared to 
control ponies (Coffman and Colles 1983, Jeffcott et al. 1986). Current 
experimental and field studies have shown that insulin dysregulation 
(hyperinsulinemia and/or insulin resistance) is a key factor of EMS and 
endocrinopathic laminitis (Treiber et al. 2006, Asplin et al. 2007, Carter et al. 
2009, de Laat et al. 2010). The horse is unique in that it can produce large 
amounts of insulin without hyperglycemia or pancreatic exhaustion (Reeves et 
al. 2001, McGowan et al. 2004) and therefore hyperinsulinemia is considered 
the hallmark of insulin resistance in horses. In addition to EMS related 
laminitis (Treiber et al. 2006, Frank et al. 2010), there is also support for the 
role of hyperinsulinemia in the pathogenesis of laminitis in horses with PPID. 
Horses with very high serum insulin concentrations at presentation (> 188 
µIU/ml) have been shown to be more prone to laminitis and to have a worse 
prognosis for survival (< 2 years) than horses with normal to moderately 
increased serum insulin concentrations (< 62 µIU/ml) (McGowan et al. 2004).  
The pathogenesis of laminitis associated with insulin dysregulation is not 
fully understood. However, several theories, like impaired glucose uptake, 
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glucose excess or vascular and pro-inflammatory changes associated with 
insulin resistance have been suggested. Research regarding lamellar glucose 
deprivation due to decreased uptake and the following cellular death or 
damage has been controversial. The lamellar tissue appeared to utilize glucose 
exceptionally fast and when lamellar explants were incubated without glucose 
and with a glucose uptake inhibitor, a rapid separation of tissue layers 
occurred (Wattle and Pollitt 2004). However, the explant study did not 
provide another source of energy for the lamellae - so the rapid death of the 
tissue following inhibition of glucose is unsurprising. Nonetheless, this led to 
a prevailing theory that insulin resistance may reduce insulin mediated 
glucose uptake in lamellae. In another study glucose uptake in lamellar tissue 
was not influenced by the presence of insulin and was shown to mainly rely on 
insulin independent glucose transporter type 1 (GLUT1) receptors, dispelling 
the idea that reduction in insulin mediated glucose uptake in lamellae could 
be a cause of endocrinopathic laminitis (Asplin et al. 2011). Another theory for 
the lamellar damage was glucose excess, an important component in diabetic 
disease in humans. The accumulation of glucose in cells (glucotoxicity) 
promotes the formation of advanced glycation end-products (AGEs) and after 
binding to their receptors, AGEs increase release of reactive oxygen species 
(ROS) and cytokines damaging susceptible tissues like lamellae (Brownlee 
2005). However, in lamellar samples acquired from horses with insulin-
induced laminitis, there was no accumulation of AGEs and no increase in ROS 
or up-regulation of AGE receptor (RAGE) compared to controls (de Laat et al. 
2012b). Also, naturally occurring cases of insulin resistance or dysregulation 
are rarely hyperglycemic (Treiber et al. 2006). Therefore, this theory is 
unlikely to explain the lamellar damage either. The activities of 
metalloproteases (specifically MMP-2, 9 and 14 and ADAMTS-4), that are 
components of the extracellular matrix capable of degrading different proteins 
and molecules, have been shown to increase in the developmental phases of 
inflammatory laminitis (Woessner 1993, Kyaw-Tanner and Pollitt 2004, 
Loftus et al. 2006, Kyaw-Tanner et al. 2008, Coyne et al. 2009). However, in 
horses with experimentally induced hyperinsulinemic laminitis no significant 
metalloprotease activity was observed in the developmental and acute stages 
of laminitis. The only metalloprotease that was activated at later stages was 
MMP-9, which is neutrophil-associated and not important in the 
developmental phase of laminitis (de Laat et al. 2011b). Therefore, it is unlikely 
that metalloproteases have a significant role in the development of 
hyperinsulinemic laminitis. 
After binding to its receptor, insulin may have either metabolic effects via 
the phosphatidylinositol 3-kinase (PI-3K) pathway, or mitogenic and growth-
related effects via the mitogen-activated protein kinase (MAPK) pathway. The 
metabolic effects of PI-3K pathways include, for example, the uptake and 
disposal of glucose and lipids and nitric oxide mediated vasodilatation. 
However, in a state of insulin resistance and hyperinsulinemia, the MAPK 
pathways dominate and convey mitogenic signals including endothelin-1 (ET-
1) mediated vasoconstriction, vascular adhesion molecules and proliferation 
of vascular smooth muscle cells leading to endothelial dysfunction (Cusi et al. 
2000, Kim et al. 2006). This dominance of signaling via the MAPK pathway 
has been shown to be central to insulin resistance and subsequent metabolic 
dysfunction including dyslipidemia, vasculopathy and coagulopathy in murine 
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models and human patients (Kim et al. 2006). The vascular and pro-
inflammatory effects of insulin have been shown to be important components 
of human metabolic disorders like cardiovascular disease and are likely to 
contribute also to the development of endocrinopathic laminitis. Insulin 
resistance is accompanied by endothelial dysfunction and vasoconstriction in 
many metabolic diseases and obesity in humans (Kim et al. 2006). 
Interestingly, insulin has been shown also to affect equine blood vessel tone ex 
vivo (Venugopal et al. 2011, Keen et al. 2012, Wooldridge et al. 2014). In one 
study, vasoconstriction was noticed in insulin resistant arterial and venous 
rings from the palmar digital vessels in response to insulin. In addition, in 
explants where MAPK was blocked, the vasoconstriction was not detected, 
which suggests that it is MAPK dependent (Venugopal et al. 2011). In another 
study, insulin pre-incubation decreased phenylephrine and ET-1-mediated 
venoconstriction (Keen et al. 2012) and in a third study, the pre-incubation 
resulted in the reduced relaxation of arteries following contraction with 
phenylephrine (Wooldridge et al. 2014). Therefore, it has been suggested, that 
the vascular dysfunction has role in development of hyperinsulinemic 
laminitis; however, the exact mechanism warrants further research. 
2.4 The relevant anatomy and histology of the hoof 
 
The equine foot consists of a horny hoof capsule and the enclosed structures 
that include: the DP, the distal part of the middle phalanx, the navicular (distal 
sesamoid) bone, 11 ligaments and 2 tendons (common digital extensor tendon 
and deep digital flexor tendon) (Stump 1967). The hoof capsule is epidermal 
in origin and includes the hoof wall, sole, frog and heel bulbs (Figure 5). The 
hoof wall originates and grows down 0.143-0.48 mm per day (Reilly et al. 
1998) from the germinal epithelium of the coronary corium. It consists of three 
layers: the stratum externum, the stratum medium and the stratum 
internum/lamellatum (Figure 6). The stratum externum is the thin outermost 
layer whereas the stratum medium is the thickest of the three layers, 
characterized by tubular (oriented proximo-distally) and intertubular 
(between the tubules) horn. The intertubular horn forms at right angles to 
tubules, which makes the hoof wall an extremely tough structure (Pollitt 
2004). The tubule density is greatest at the abaxial edge of the wall and 
decreases towards the axial side, which smoothes energy transfer to the distal 
phalanx (Lancaster et al. 2013). 
The lamellar region or stratum internum/lamellatum is the innermost 
layer of the hoof wall that bridges the distal phalanx and hoof capsule (Pollitt 
2010).  This dermo-epidermal arrangement provides a large surface area of 
attachment (average 0.8 m, Daradka 2000) between the bony column (via DP) 
and the hoof capsule, therefore enabling the DP to remain suspended within 
the hoof capsule by counteracting the downward forces of the animal’s weight 
(Davies et al.  2007). Disruption of the mechanical stability of the lamellar 
region occurs at both microscopic and macroscopic levels in cases of laminitis, 
which may lead to pain and disruption of the normal anatomical arrangement.  
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Figure 5. A sagittal section of the distal limb of a horse showing the structures either fully or 
partly consisting the foot: distal phalanx (1), middle phalanx (2), navicular bone (3), hoof wall 
(4), lamellar region (5), deep digital flexor tendon (6), common digital extensor tendon (7), sole 
(8) and heel (9).  
 
 
 
 
 
 
Figure 6. A sagittal section of an equine hoof removed from a sagittally bisected equine distal 
limb (A). A transverse section of the dorsal hoof which has been cut from the sagittal section 
of figure A (dashed line) and turned 90°, showing the distal phalanx (1), sublamellar dermis 
(2), lamellar region (stratum internum, 3) and stratum medium (4) (B). The thin outermost layer 
(stratum externum) cannot be distinguished in this image. 
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Lamellar tissue consists of primary and secondary in-foldings, called 
lamellae. In the normal hoof there are 550-600 primary lamellae each with 
150-200 secondary lamellae, which are orientated towards the distal phalanx 
(Figure 7; Pollitt 2010). Lamellae have been traditionally defined as 
interleaved ‘epidermal lamellae’ (with keratinized centers) extending in from 
the hoof capsule and ‘dermal lamellae’ arising from the dermis that is attached 
to the DP by dense type I collagen fibers (Pollitt 2010, Engiles 2010). However, 
the epidermal component is actually modified and further specialized 
epidermal tissue, similar to skin with rete pegs. As such ‘epidermal lamellae’, 
as previously defined, are embryologically impossible (Bragulla 2003). For the 
purposes of this dissertation the term ‘epidermal lamellae’ refers to the 
primary or secondary lamellar structure of an epidermis overlying the dermis 
that it developed with.  The embryological development of lamellae starts at 
around 4 weeks gestational age when a single layer of ectodermal cells covers 
the mesenchyme. The epidermis derives from these ectodermal cells and the 
dermis from the subjacent mesenchyme. At a gestational age of 65-70 days the 
epidermal cells start to invade the dermis to form microridges, and some of 
these enlarge to become primary (PDL) and secondary dermal lamellae (SDL). 
The epidermal cells proliferate and form primary (PEL) and secondary 
epidermal lamellae (SEL) (Bragulla 2003). Before birth, the lamellae have a 
homogenous appearance and symmetric distribution around the hoof. After 
birth, however, the lamellar region undergoes rapid changes including PEL 
branching, with a greater density at the toe than the quarters (Bidwell and 
Bowker 2006). These changes are likely a response to mechanical stress 
(weight bearing) and indicate that lamellae architecture can change 
physiologically as well as pathologically.  
 
 
Figure 7. A histological (hematoxylin and eosin) section of normal lamellar region showing 
stratum medium (1), standard type of primary epidermal lamella (2), curved type of primary 
epidermal lamella (3), primary dermal lamella (4) and sublamellar dermis (5). 
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The epidermal covering of the lamellae merges with the keratin of the 
stratum medium, which is a product of coronary germinative epidermal cells. 
On the base of the epithelial cells, the epidermis attaches to the dermis via a 
basement membrane, which is produced by both epidermal and mesenchymal 
(dermal) cells (Marinkovich et al. 1993). The BM is composed mostly of type 
IV collagen, laminin, heparin sulfate proteoglycan and nidogen – the basal 
epidermal cells, as in normal skin, are connected to the BM by 
hemidesmosomes. The BM has a critical role in anchoring the epidermis and 
dermis together, but it also participates in other biological processes between 
these two tissues. Therefore, damage to the BM has been thought to have a key 
and possibly primary role in the pathogenesis of laminitis (Pollitt 1996). 
However, the BM is also reliant on the health of the epidermal and dermal cells 
and can be affected secondarily by cell damage (Marinkovich et al. 1993). 
The normal morphology of the lamellar region is variable, in terms of 
lamellar length, width, orientation and type. Possible factors affecting the 
lamellar morphology may include age, weight and the mechanical 
environment (Kawasako et al. 2009, pers. observation).  However, the 
descriptions of normal lamellar histology are few and therefore it can be 
challenging for the pathologist or researcher to distinguish true pathological 
changes from normal morphological variation. Recently, a classification 
system for the morphology of primary and secondary epidermal lamellae in 
‘normal’ horses was described. Lamellar samples from 35 Thoroughbred 
cadavers showed great histological diversity, for example predominance of the 
so-called hyperplastic SEL type in axial regions, were detected apparently 
independently of clinical signs of laminitis. It was suggested that diagnosing 
or grading the severity of laminitis based on histological evaluation only would 
not be advisable. However, some of the hooves studied were from horses 
euthanized due to systemic inflammatory disease (e.g. colic, pleuropneumonia 
and placental retention). Subclinical or early lesions of inflammatory laminitis 
may have been present in these horses and the results should be interpreted 
carefully (Kawasako et al. 2009).  
2.5 Histopathology of experimentally induced 
hyperinsulinemic laminitis 
The first clear evidence of the link between hyperinsulinemia and laminitis 
was provided in a study in which laminitis was induced in 5/5 previously 
healthy, young and lean ponies by exposing them to prolonged 
hyperinsulinemia (> 1000 µIU/ml) while maintaining euglycemia (5 
mmol/L); this was done using a modified (prolonged) euglycemic-
hyperinsulinemic clamp technique (pEHC, Asplin et al. 2007). Subsequently, 
this experimental model was repeated in Standardbred horses with similar 
results. All of the exposed animals developed laminitis within 48 hours (de 
Laat et al. 2010). In these two studies, animals were euthanized and the 
lamellar samples were collected at the onset of Obel grade 2 laminitis that 
occurred at a mean of 46h in horses and at 55h in ponies. Horses developed 
laminitis more rapidly than some ponies, possibly due to their larger body 
weight, but there was greater temporal variability in ponies, with Obel grade 2 
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laminitis developing over a range of 37-61 hours. Since the magnitude of 
hyperinsulinemia is very high during pEHC and laminitis develops in 
approximately 48h, the pEHC model represents an exaggerated form of the 
naturally occurring disease. Therefore, in a later study much lower insulin 
concentrations (~ 200 µIU/ml) were induced in four insulin sensitive 
Standardbred horses by administering continuous intravenous infusion of 
glucose for 48h. None of the animals developed clinical laminitis but all of 
them had histological evidence of lamellar disease in at least one foot (de Laat 
et al. 2012a). 
The lamellar histology of both ponies and horses after 46-55 hours of 
hyperinsulinemia demonstrated some clear differences as well as some 
histological similarities to previously reported non-endocrinopathic 
(inflammatory) forms of the disease. Both models - hyperinsulinemic and 
inflammatory - had similar early histological changes. There was a loss of the 
normal perpendicular orientation of SEL nuclei relative to their basement 
membranes, with the nuclei becoming rounded, more central within the 
cytoplasm (rather than apical) more randomly oriented, and containing 
prominent nucleoli (Obel 1948, Pollitt 1996, Asplin et al. 2010, de Laat et al. 
2011a, de Laat et al. 2012a). At the same time the SEL started to elongate, 
become narrower, develop tapered (rather than club-shaped or rounded) tips, 
and become more acutely angled to the PEL axis, with irregularity of the 
PEL/SEL interface. The PEL and SEL become more closely apposed and were 
often difficult to distinguish from each other.    
In some inflammatory models (CHO overload) of laminitis, severe BM 
damage has been described as the predominant and perhaps primary feature 
of laminitis (Pollitt 1996, Nourian et al. 2007). Diagrams depicting a 
‘degloving’ type of disruption were based on observations of separation of 
lamellar explants under certain conditions (MMP-activator 
aminophenylmercuric acetate; Pollitt 2004). Interestingly, BM damage has 
not been found in all CHO overload models, with one group noting that the 
BM remained intact and attached during the acute phase of laminitis (Morgan 
et al. 2003). Also in hyperinsulinemic (pEHC) models, BM damage was found 
to be minimal and predominantly localized to the most axial SEL only (and not 
in all specimens/animals) (Asplin et al. 2010, de Laat et al. 2011a, de Laat et 
al. 2012a). 
2.6 Histopathology of naturally occurring laminitis 
Naturally occurring endocrinopathic laminitis is a chronic process and, 
therefore, the induction models do not represent it very well. The lamellar 
lesions in insulin induction models are always acute whereas in animals with 
naturally occurring disease the lesions may have been developing for months 
or even years. However, the hyperglycemic model in which moderate 
endogenous hyperinsulinemia is induced by administering only glucose, may 
be used to mimic the preclinical phase of naturally occurring hyperinsulinemic 
laminitis. In one study, none of the treated horses became lame 48 h after the 
glucose infusion; however, they all had histological evidence of lamellar 
disease in at least one foot, including elongation and narrowing of the SELs as 
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well as increased evidence of mitosis and apoptosis (de Laat et al. 2012a). This 
suggests subclinical lamellar disease, likely to not be noticed by owners or 
veterinarians, which, if it appears recurrently, could ultimately lead to 
laminitis. 
Histological descriptions of naturally occurring laminitis are few and 
many of them lack adequate clinical details of the sampled animals, including 
the associated systemic disease condition (Roberts 1980, Kuwano et al. 2002, 
Kuwano et al. 2005, Hampson et al. 2012). Additionally, some studies have 
used horses exposed to different or several etiologies and should therefore be 
interpreted carefully (Carter et al. 2011, Engiles et al. 2015). Engiles et al. 
(2015) presented histological findings in a study aiming to correlate osteology 
and imaging in chronically laminitic hooves of different etiologies. However, 
the cases included laminitis cases with exposure to one or more risk factors 
confirmed at necropsy: endocrine (obesity, PPID), inflammatory (e.g. visceral 
inflammatory disease) or supportive limb overload. In addition, they included 
animals in the ‘normal’ control group of which 3/5 had also risk factors 
(obesity, colitis and supporting limb overload) - those animals may therefore 
have had subclinical lamellar disease. Histologically, SEL elongation, thinning 
and distortion with duplication/splitting of the BM, accumulation of 
suprabasilar cells and distortion of the keratinized axes were noticed in 
animals with mild acute or subclinical laminitis.  In animals with severe 
chronic laminitis the lesions included epidermal lamellar necrosis with BM 
separation and dysplastic regeneration, including acanthosis and 
hyperkeratosis, corresponding to a lamellar ‘wedge’ (Engiles et al. 2015). In an 
earlier study Carter et al. (2011) used a hoof lamellar tissue bank in horses with 
very limited clinical histories in a study investigating the transcription factor 
p63, as a potential determinant of the proliferative capacity of hoof lamellar 
epidermal cells in laminitis. They also included cases with different or several 
etiologies. Additionally, they had 2/5 horses in their control group with 
possible PPID (pituitary adenoma) - therefore the mild axial PEL and SEL 
distortion noticed in these animals may have been a result of subclinical 
lamellar disease/preclinical laminitis. However, the animals with clinical 
laminitis had more severe elongation and distortion of PELs and SELs. 
Additionally, the histological findings included lamellar epidermal 
hyperplasia and acanthosis with hyperkeratosis, abaxial displacement of the 
keratinized axis with frequent merger of adjacent abaxial lamellae and BM 
pathology (separation, splitting, duplication and epidermal island formation) 
(Carter et al. 2011). Neither of the studies performed endocrine screening on 
all the horses and both included multiple etiologies. Therefore, as far as the 
author is aware, there are no previous studies on the histopathology of clearly 
defined naturally occurring endocrinopathic laminitis. In addition, there are 
no studies where the histology has been compared with clinically healthy 
control animals with no risk factors for laminitis/lamellar alteration. 
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3 AIMS OF THE STUDY 
The aims of this thesis were  
i. To determine whether an underlying endocrinopathy 
(hyperinsulinemia or PPID) was present in laminitic horses 
presented to a first-opinion/referral veterinary teaching hospital 
and to compare the signalment of laminitic horses to equine 
hospital population during the same period.  
 
ii. To determine cellular changes associated with secondary epidermal 
laminar (SEL) lengthening in forefeet and hind feet of experimental 
ponies with insulin-induced laminitis. 
 
iii. To describe the histomorphometry and pathological lesions in hoof 
lamellar tissue of horses and ponies with naturally occurring 
endocrinopathic laminitis, with reference to age- and breed-
matched controls. 
 
iv. To describe the histomorphometry and pathological lesions in hoof 
lamellar tissue of animals that had PPID with or without concurrent 
laminitis, with reference to age-matched controls 
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4 MATERIALS AND METHODS 
The study protocols were approved by the following authorities: The Animal 
Ethics Committee of the University of Queensland, Australia (Study II) and 
the Research Ethics Committee of the University of Helsinki, Finland with 
individual institutional ethical approval (University of Liverpool and 
University of Oklahoma) where applicable (Studies III and IV). 
For more detailed information on the materials and methods, see Studies I-IV. 
4.1 Horses 
Study I 
 
A total of 410 horses (229 males and 181 females) were recruited for the study 
between April 2007 and August 2008, representing 37 horses presented with 
current or historical laminitis and 373 nonlaminitic, hospitalized horses 
(control group) at the Helsinki University Equine Teaching Hospital, Finland. 
Study II 
 
Eight clinically healthy ponies (six geldings, one colt, one mare), aged 6.3 ± 1.7 
years old (244.1 ± 32 kg) (mean ± s.e.), with no known history of laminitis, and 
no evidence of previous laminitis on inspection of the hooves were included in 
the study. Four of the ponies were randomly allocated to a treatment group 
and 4 to a control group. 
 
Study III 
 
Altogether 39 animals that had presented to the Helsinki University Equine 
Teaching Hospital, Finland or the Philip Leverhulme Equine Hospital, 
University of Liverpool, UK for euthanasia or were humanely killed at local 
stables or in abattoirs, were included in the study between March 2010 and 
September 2013. In addition, four archived samples from a previous study 
(control ponies) were used (Asplin et al. 2010). Animals were divided into 5 
groups: young (<12 yrs., n=11) and old (≥12 yrs., n=5) control ponies, young 
(<12 yrs., n=4) and old (≥12 yrs., n=5) control horses and animals with 
endocrinopathic laminitis (n=14; 4 horses, 10 ponies). All animals under one 
year old and/or current evidence or a known history of systemic inflammatory 
disease were excluded. 
 
Study IV 
 
Twenty-six animals (10 ponies and 16 horses) that had presented to the 
Helsinki University Equine Teaching Hospital, Finland or the Philip 
Leverhulme Equine Hospital, University of Liverpool, UK for euthanasia, were 
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humanely killed at local stables or in abattoirs or belonged to a PPID research 
herd (Oklahoma State University, USA) were included in the study between 
March 2010 and September 2013. In addition, one archived sample from a 
previous study (control pony) was used (Asplin et al. 2010). Of the study 
population, 10 animals (5 ponies and 5 horses) were clinically healthy and had 
no evidence of endocrinopathic disease or laminitis. The remaining 16 animals 
(5 ponies and 11 horses) had PPID and of these, 6 had also laminitis (4 ponies, 
2 horses). Only animals that were older than 12 years and had no evidence or 
history of systemic inflammatory disease were included. 
4.2 Diagnosis of laminitis 
Laminitis was diagnosed by an equine veterinarian/s in all 4 studies. The 
diagnosis was made based on physical examination identifying lameness in 
both front hooves or all 4 hooves associated with weight shifting, a typical saw 
horse stance and/or reluctance to move. Supportive signs included increased 
digital arterial pulses, sensitivity to hoof tester pressure applied at the toe of 
the affected foot/feet and macroscopic hoof alterations in chronic cases 
(divergent rings in the outer hoof wall, flat or convex soles, widened white 
line). Radiographs were taken, when indicated, to confirm evidence of lamellar 
disruption including DP sinking and/or rotation. 
4.3 Induction of laminitis with prolonged euglycemic-
hyperinsulinemic clamp (Study II) 
In Study II, archived samples from a previous experiment were used (Asplin 
et al. 2007). In this experiment laminitis was induced in 4 ponies using the 
prolonged euglycemic-hyperinsulinemic clamp (pEHC) technique. These 
ponies received recombinant insulin (Humulin R™, Eli-Lilly Australia, West 
Ryde, New South Wales, Australia) and glucose IV while control ponies (n=4) 
received an equivalent volume of saline solution (0.9% NaCl) IV. For 
treatment group ponies, one jugular venous catheter was used for the 
simultaneous administration of insulin at a fixed rate and glucose at a variable 
rate to maintain euglycemia (blood glucose concentration, 5 mmol/L). A 
catheter in the other jugular vein was used to collect blood samples for 
monitoring of blood glucose and insulin concentrations. After collection of 
baseline blood samples, insulin (45 mU/ kg in 50 mL of saline solution as a 
bolus followed by 6 mU/min/kg for the duration of the experiment) was 
administered IV. Intravenous administration of 50% glucose solution (Baxter 
Healthcare Pty Ltd, New South Wales, Australia) was initiated at a mean ± SE 
rate of 24.4 ± 3.0 mmol/min/kg. The glucose administration rate was adjusted 
when blood glucose concentrations differed from the target concentration (5 
mmol/L) by > 1 mmol/L. Control ponies received saline solution (14.7 
mL/min/kg for 72 hours, which was the mean rate of fluid administration for 
treatment group ponies during the same period). Infusions were continued 
until Obel grade 2 (Obel 1948) laminitis occurred or for a maximum of 72 
hours. 
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4.4 Collection of lamellar and blood samples 
4.4.1 Lamellar samples (Studies II-IV) 
For each horse/pony, the distal aspect of all 4 limbs (Study II) or right forelimb 
(Studies III-IV) was disarticulated at the metacarpophalangeal or 
metatarsophalangeal joint within 1 h of death and sectioned with a band saw, 
as soon as possible. In Study II, the hooves were sectioned as previously 
described (Pollitt 1996). Briefly, the sole on the base plate of the band saw, the 
first cut was made medial to lateral just palmar to the coronary band. Then a 
15 mm sagittal section was obtained from the dorsal midline by cutting on 
either side of the frog and after that, most of the hoof wall and DP were 
removed. Then a 15 mm wide sample was cut from the mid-wall region; a 
scalpel blade was used to cut the sublamellar dermis from the distal phalanx.  
Finally, the sample was dissected to obtain 5 mm square explants, extending 
from the inner hoof wall to the dermal connective tissue. All samples were 
fixed in 10% neutral buffered formalin for 24h, processed by routine methods, 
embedded in paraffin wax and sectioned at 5 µm. In Studies III and IV, Pollitt’s 
method was slightly modified. First, the foot was bisected sagittally. Then, a 1 
cm thick parasagittal section was cut from one half of the hoof; this specimen 
included the hoof wall, lamellar tissue and most of the DP. The midpoint 
between the coronary band and the ground-bearing surface was identified on 
the dorsal aspect of this section. A square or rectangular segment including 
the dorsal cortex of the DP was excised, and then a 0.5 mm thick transverse 
section cut from its lower face (at the previously described mid-point). From 
that transverse section (in which lamellar detail should be seen), the dense 
hoof wall (often pigmented) was removed to within approximately 1 mm of the 
abaxial aspect of the lamellar tissue using a single edge razor blade (scalpel 
blades are not sufficient for this step). The phalangeal bone was then removed, 
by running a scalpel blade along its dorsal edge. Each specimen was divided 
into 5 mm wide (square) blocks that were fixed in 4% paraformaldehyde for 
24-72 h before processing by routine methods and embedding in paraffin wax. 
These blocks were oriented with the longitudinal axes of the PEL parallel to 
the cutting edge; if oriented perpendicularly (i.e. incorrectly) the remaining 
horn at the abaxial aspect of the lamellar tissue was likely to fold over during 
section cutting. 
4.4.2 Blood samples (Studies I-IV) 
Blood samples were collected from the jugular vein for the measurement of 
insulin, ACTH, cortisol and glucose concentration. In Studies I, III and IV 
blood samples for basal serum insulin concentration were collected in serum 
sample tubes following at least 2 hours of fasting (Vacuette®, Greiner bio-one, 
2 serum clot activator). In Study II the ponies had access to lucerne hay during 
the blood collection for basal insulin. After the collection, the samples were 
centrifuged and the serum was separated within 3 hours. In studies I, III and 
IV serum samples were frozen to -20˚C and sent by courier to the laboratory 
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by next day delivery; however, in Study II the samples were stored at –80 °C 
until analyzed. 
Blood samples for ACTH concentration were collected in 10 mL plastic 
EDTA tubes (Vacuette®, Greiner bio-one, EDTA K3). Plasma was separated 
and frozen in plastic tubes within 1 hour and sent frozen by courier to the 
laboratory. The samples were taken, when possible, in the morning when the 
stable environment was quiet and the horse was calm. Samples were not taken 
during the acute phase of pain or from abattoir horses, to reduce the possibility 
of stress-related elevation in plasma ACTH concentration.  
Blood samples for cortisol measurements for the dexamethasone 
suppression test were collected in 6-mL serum sample tubes (Vacuette®, 
Greiner Bio-One, 2 serum clot activator). After collection, the serum was 
separated and sent by mail to the laboratory. 
Blood samples for basal glucose measurement in Studies III and IV were 
collected in 2 mL plastic lithium heparin tubes following at least 4 hours of 
fasting (Vacuette®, Greiner bio-one). In Study II glucose concentrations were 
measured in 1 mL blood samples.  
4.5 Analysis of blood samples 
In Study I insulin analysis was performed with the DiaSorin S insulin 
radioimmunoassay (RIA) validated for use in horses (Cambridge Specialist 
Laboratories, UK). In Study II the analysis was performed with another RIA 
kit validated for use in horses (Diagnostic Systems Laboratory; Charles Sturt 
University, Wagga Wagga, Australia). In Studies III and IV insulin analysis 
was performed using a chemiluminescent immunoassay (Immulite®, 
Liphook Equine Hospital, UK or Laboratory of Comparative Aging Research, 
Center for Veterinary Health Sciences, Oklahoma State University, Oklahoma, 
USA).  
Quantitative plasma ACTH analysis was performed in Study I by a 
commercial two-site, solid-phase immunoradiometric assay (Mitsubishi, 
Japan) and in Studies II-IV by using a chemiluminescent immunoassay 
(Immulite®). In Study I, the analyses were performed at Cambridge Specialist 
Laboratories, UK; in Study II at VETPATH laboratory services, Ascot, Western 
Australia; in Study III at the Liphook Equine Hospital, UK; and in Study IV 
either at the Liphook Equine Hospital, UK or at the Laboratory of Comparative 
Aging Research, Center for Veterinary Health Sciences, Oklahoma State 
University, Oklahoma, USA.  
In Study I, cortisol analysis (dexamethasone suppression test) was 
performed using a chemiluminescent immunoassay (Siemens Immulite 2000; 
Vetlab, Tampere, Finland).  
In Studies II-IV glucose concentrations were measured using a portable 
glucometer. In Study II an Advantage (Roche Diagnostics) glucometer was 
used and in Studies III and IV either Ascensia Contour® (Bayer HealthCare, 
Germany) or AlphaTRAK® (Abbott Laboratories, Abbott Park, Illinois, USA) 
glucometers.  
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4.6 Diagnosis of hyperinsulinemia and PPID 
Basal fasting (≥ 2 hours) hyperinsulinemia indicative of insulin resistance was 
diagnosed in Studies I, III and IV in animals having basal serum insulin values 
> 30 µIU/ml (Study I) or > 20 µIU/ml (Studies III and IV). In addition, in 
Study I the reciprocal of the square root of insulin (RISQI, [basal insulin 
µIU/ml]-0.5) was calculated as a proxy measurement of insulin sensitivity and 
values of ≤ 0.18 were considered indicative of insulin resistance (lowered 
insulin sensitivity).  
PPID was diagnosed on the basis of clinical signs and a diagnostic test 
(Studies I, III and most cases in Study IV) or on the basis of clinical signs and 
pituitary pathology (hyperplasia, microadenomas or macroadenoma; Miller et 
al. 2008) (2 animals from Oklahoma subgroup of Study IV). Clinical signs 
included hypertrichosis, muscle wastage, hyperhidrosis, polyuria/polydipsia 
and abnormal fat distribution. Diagnostic tests included basal plasma ACTH 
measurement and/or the dexamethasone suppression test. A plasma ACTH 
value of > 300 pg/mL (immunoradiometric assay; Study I) or > 29 ng/L from 
November to July and > 47 ng/L from August to October (chemiluminescent 
immunoassay; Studies III and IV) were considered positive for PPID. The 
dexamethasone test was considered positive for PPID if there was a failure to 
suppress cortisol to values < 27.6 nmol/L in 20 to 24 h after dexamethasone 
administration (Dybdal et al. 1994). In Study I diagnostic tests for PPID were 
not performed during the autumn months (August to October) to avoid 
seasonal variation in blood hormone concentrations. 
4.7 Evaluation of obesity 
The body condition was scored in all 4 studies using the Carroll and 
Huntington 0 to 5 body condition score (BCS; Carroll and Huntington 1988). 
In Study I, laminitic horses were considered overweight if their BCS was >3 
and nonoverweight if their BCS was ≤3. A cresty neck score of ≥3/5 (Carter et 
al. 2009) and the presence of bulging supraorbital fat were also considered 
indicative of obesity and EMS. 
4.8 Histomorphometry and categorization of lamellae 
Lamellar histomorphometry was described in Studies II-IV. First, histological 
sections were stained using hematoxylin and eosin (HE) and periodic acid-
Schiff (PAS) methods and then examined using a light microscope. The HE 
sections were used for detection of lamellar lesions, and the PAS sections for 
morphometry. Digital images were taken using image capture software 
(Cell^D version 2.8, Olympus Soft Imaging Solutions, Münster, Germany) and 
a microscope-attached digital camera (Olympus DP71, Olympus Imaging 
America Inc., Center Valley, Pennsylvania, USA).  For PEL measurements, 
images were taken at 40x magnification and then merged (to image the 
complete PEL) (Adobe Photoshop CS5 version 12.0 x64, Adobe Systems 
Incorporated, San Jose, California, USA).  For SEL typing, images were taken 
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at 200x magnification from abaxial (adjacent to keratinized hoof wall), 
middle, and axial (adjacent to DP) regions of 10 randomly selected PEL 
(http://www.randomizer.org/form.html). These regions were defined as 10%, 50% 
and 90% of the length of the PEL, respectively. 
All of the measurements were made using a drawing tool (Wacom Intuos4 
or Bamboo, Wacom Europe, Krefeld, Germany) and image analysis software 
(ImageJ version 1.4.3, National Institutes of Health, Bethesda MD, USA. 
Available at: rsbweb.nih.gow/ij/index.html) from 10 randomly selected PEL. 
PEL length (PELL) was measured by drawing a continuous line from the axial 
tip of the PEL to the level of the base. The width of a PEL (PELW) was 
measured in Study II at a location 50% along the length of the measurement 
line for that lamina; this measurement was determined from the tips of the 
SEL on one side to the tips of the SEL on the other side. In Study IV PELW was 
measured from the bases of the SELs on one side to the bases of the the SELs 
on the other. 
The SEL length, width, and angle were measured in Study 2 for 10 
randomly selected SELs (5 from the left side and 5 from the right side of the 
PEL) at 200X magnification from each of the 3 aforementioned regions of 
randomly selected PEL. The lengths of the SELs were measured from the tip 
to the base of such lamina at the junction with the keratinized axis of the 
associated PEL. The widths of the SELs were measured from basement 
membrane to basement membrane at the longitudinal midpoint of each SEL 
(identified along a straight line). The angle between the axes of the PELs and 
those of SELs was measured with the angle tool in the image analysis software.  
In Study 2, the number of epidermal cell nuclei per SEL was counted from 
an SEL base to the tip for 10 randomly selected SELs from each of the 3 regions 
of a randomly selected PEL (as for measurement of the other SEL variables). 
The number of epidermal cell nuclei per micrometer of an SEL was calculated 
by dividing the number of cell nuclei by the SEL length (for an individual SEL). 
Percentage differences between the control and treatment group ponies were 
calculated for each variable (PEL length and width; SEL length, width, and 
angle; cell number per SEL; and cell number per micrometer of an SEL). 
In Studies III and IV, the PEL type was defined as standard (straight) or 
curved (with 2 or more bends), and bifurcations were reported when present 
(Figure 7). The axial region (tip) of PEL was defined as standard, tapered, 
sharp or bifurcated; and the abaxial region (base) as standard, sharp, 
bifurcated, ‘proliferative’ (epidermal cells bridging dermal tissue), separated 
(i.e. epidermal and dermal lamellae had torn apart), or keratinized 
(dyskeratosis of the bridging epidermal cells). The SEL types were defined as 
standard, tapered, club-shaped, suprabasal layer hyperplasia, bifurcated, 
fused, separated or keratinized. The degree of abaxial dyskeratosis (increased 
keratinization), i.e. in the ‘cap horn’ region was graded as normal, slightly (1-
10 extra layers), moderately (10-30 layers), or markedly increased (>30 
layers). The degree of epidermal tissue bridging a PDL at its abaxial aspect (i.e. 
joining the adjacent PEL) was defined as none, mild (1-2 epithelial bridges), 
moderate (> 2 epithelial bridges) or extensive (abaxial region completely filled 
with epidermal cells). Lakes within the cap horn or bridging abaxial epidermal 
tissue were defined as small to large cavities that were either empty (most 
likely due to processing artifact) or filled with homogeneous eosinophilic 
(proteinaceous) material. Epithelial islands were defined as isolated round or 
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ovoid structures adjacent to a PEL; their presence in the different regions was 
noted (abaxial, middle, axial). 
4.9 Quantification of apoptotic cells 
In Studies II-IV, apoptosis of SEL cells was confirmed on the basis of 
morphological criteria, including cytoplasmic rounding, nuclear shrinkage, 
chromatin condensation and fragmentation, and formation of apoptotic 
bodies (Meyers et al. 2007, Figure 8). Some of the apoptotic bodies had been 
phagocytosed by neighboring epithelial cells. In Study II, the numbers of 
apoptotic cells per 200X field were counted for each of the 3 regions (axial, 
middle, and abaxial) of randomly selected PEL (n = 10/hoof) in HE-stained 
sections. In Studies III and IV, the numbers of apoptotic cells were visually 
evaluated for each PEL region in HE sections and apoptotic cell death was 
further confirmed by immunolabeling for gamma-H2AX, a marker of double-
strand DNA breaks. First, the sections were deparaffinized (Histo-Clear, 
National Diagnostics, Hull, UK) and rehydrated using graded alcohols. 
Antigen retrieval was required for anti-gamma-H2AX immunolabeling; this 
was performed by placing slides in sodium citrate buffer (pH 6.0) for 1 minute 
and 40 seconds using a pressure cooker (Antigen Access Unit, A. Menarini 
Diagnostics Ltd., Wokingham, UK). All the slides were then loaded into a 
Dako-Autostainer (Dako UK Ltd., Ely, UK). Endogenous peroxidase and 
nonspecific staining were blocked using 3% hydrogen peroxide (in PBS) for 5 
minutes. All sections were incubated with a primary mouse monoclonal 
antibody against gammaH2AX (clone JBW301 (1:500); Millipore, Watford, 
UK) for 30 minutes at room temperature (RT). An anti-mouse secondary 
antibody conjugated to an HRP-labeled polymer ((K4003) Dako Envision™ + 
System-HRP, Dako UK Ltd.) was then applied for 30 minutes at RT. 
Visualization was achieved using 3,3’-diaminobenzidine (DAB+ Substrate 
Chromagen system, Dako UK Ltd.), 20 µl/ml for 10 minutes. Tissues were 
counterstained using Gill’s hematoxylin (made in-house) for 27 seconds, then 
dehydrated, cleared, and mounted (DPX mounting medium, Cellpath, 
Newtown, Powys, UK). 
4.10 Quantification of mitotic cells 
In Study II, immunolocalization of proliferating cells was performed with a 
mouse monoclonal antibody (Ki-S2) to the TPX2 protein (TPX2/ab32795, 
Abcam, Cambridge, United Kingdom); TPX2 is a nuclear protein (repp86/ 
p100) associated with cell proliferation that is specific for the S, G2, and M 
phases of the cell cycle. Unlike the more commonly used 
immunohistochemical proliferation markers Ki-67 and topoisomerase-IIα 
antigens, TPX2 does not label cells in the G1 phase of the cell cycle, thereby 
avoiding inclusion of cells in damage-induced G1 arrest (Rudolph et al. 1998). 
In addition, because TPX2 is required for mitotic spindle formation, the 
antibody to that protein can label dividing cells that do not contain mitotic 
figures, which makes it superior to conventional staining techniques for the 
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detection of mitosis (Heidebrecht 1997). The TPX2 immunolabeling was 
performed with an automated stainer and a horseradish peroxidase system 
(Dako, Glostrup, Denmark). Antigen retrieval was achieved by heating 
sections in a digital electric pressure cooker (Menarini Antigen Access Unit, A. 
Menarini Diagnostics Ltd, Berkshire, United Kingdom) in sodium citrate 
buffer (pH, 6; 125°C for 1 minute and 40 seconds). This antibody to the TPX2 
protein has been validated for use with equine tissue samples by means of 
Western blot analysis and immunolabeling of positive control (epidermal) 
tissues (personal communication, Dr. Janet Patterson-Kane). Primary 
antibodies were diluted at an optimal ratio (1:800) in antibody-dilution 
solution (Dako, Glostrup, Denmark). The positive control tissue samples were 
human and equine skin samples. For negative reagent control samples (to 
exclude nonspecific binding identified by the detection system), mouse IgG 
was used instead of the primary antibody. Sections were stained with 
chromagen 3.3′-diaminobenzidine tetrahydrochloridem (Dako, Glostrup, 
Denmark) twice for 5 minutes (with an intervening Tris-buffered saline with 
Tween wash) followed by counter-staining with Mayer hematoxylin (30 
seconds). Five PELs on each slide were randomly selected, and the total 
number of cells with positive results for TPX2 in each region (axial, middle, 
and abaxial) was counted with the assistance of image analysis software 
(ImageJ version 1.4.3, National Institutes of Health, Bethesda MD, USA. 
Available at: rsbweb.nih.gow/ij/index.html). 
In Studies III and IV, mitotic cells were assessed by observing mitotic 
figures from HE sections with a light microscope. 
 
 
Figure 8. Rounded, hypereosinophilic apoptotic epithelial cells in secondary epidermal 
lamellae. HE. 
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4.11 Statistical analyses 
4.11.1 Study I 
For the comparison of groups (laminitis and hospital group) Chi-squared 
analyses were used for categorical parameters (breed and gender) and Mann-
Whitney tests (after testing for normality) for age. Results were presented as 
mean ± standard deviation (SD) or median and interquartile range (IQR) 
where applicable. Significance was set at P<0.05. 
4.11.2 Study II 
Comparisons between groups (treatment and control group) were made for 
PELL, PELW, SELL, SELW, SELA, cell number per SEL, cell number per µm 
of SEL and apoptotic and proliferative cells. All variables, except PELW, were 
not normally distributed; therefore, a non-parametric Kruskal-Wallis test with 
Bonferroni adjustment was used for pairwise comparisons. Results were 
presented as medians and IQR and significance was set at P<0.05. 
4.11.3 Studies III and IV 
Comparisons between groups were made using ANOVA for normally 
distributed parameters and a Chi-square test, Chi-square tests of 
independence, the Mann-Whitney test or Kruskal-Wallis test with Bonferroni 
adjustment were used for the parameters that were not normally distributed. 
The normality of the parameters was tested using the Shapiro-Wilk test. The 
significance level was set at P < 0.05, and results were presented as medians 
with IQR or means with confidence intervals (CI). 
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5 RESULTS 
The main results of Studies I-IV are presented below. For more detailed 
results, please see the original publications. 
5.1 Prevalence of endocrinopathic laminitis among 
horses presented for laminitis at a first-
opinion/referral hospital (Study I) 
Altogether 37 horses with current or historical laminitis and 373 nonlaminitic, 
hospitalized horses were recruited to the study at the Helsinki University 
Equine Teaching Hospital between April 2007 and August 2008. One 
laminitic horse was excluded because of missing endocrine results and 
therefore the final number of laminitic animals was 36. Evidence of 
endocrinopathy (either hyperinsulinemia, PPID or both) was present in 89% 
(32 of 36 horses; 95% CI, 74% to 97%) of laminitic horses. One third of the 
horses (11 of 32) with endocrinopathy had PPID while two thirds (21 of 32) had 
hyperinsulinemia indicating insulin dysregulation. However, 10/11 (91%) 
horses with PPID also had hyperinsulinemia. Most of the horses with 
hyperinsulinemia had phenotypic signs of EMS. All except one (20/21) were 
considered to be overweight and the mean BCS was 4.2 ± 0.65. A cresty neck 
score of ≥ 3 was noted in 16/21 (76 %), bulging supraorbital fat in 13/21 (62 %) 
and laminitic rings in 18/21 (86 %) of horses with hyperinsulinemia. Of the 
horses with laminitis and not diagnosed with an endocrinopathy (n=4), two 
had divergent rings in their hooves and phenotypic signs of EMS (BCS ≥ 4/5, 
cresty neck score ≥ 3 or bulging supraorbital fat).  
Horses with endocrinopathic laminitis were significantly older (15 vs. 9 
yrs., p < 0.001) and more likely to be pony breeds (p = 0.002) than the hospital 
population during the same period. However, no association was observed 
between sex and diagnosis of endocrinopathic laminitis (p = 0.29). 
5.2 Morphological and cellular changes in secondary 
epidermal laminae of horses with insulin-induced 
laminitis (Study II) 
The histomorphometry and number of apoptotic and mitotic cells were 
evaluated in the epidermal lamellae of four ponies with insulin-induced 
laminitis and four control ponies. The treatment group ponies were 
euthanized at the onset of Obel grade 2 laminitis, which occurred 50.3 ± 5.3 
hours after initiation of insulin and glucose infusion. The control ponies were 
euthanized after 72 hours of saline solution administration. The PEL length 
was significantly longer in the treatment group ponies than in the control 
ponies (p < 0.001; Table 1). In addition, PEL were significantly longer in the 
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forefeet than in the hind feet in both groups (p=0.015). The SEL in treated 
ponies were longer, narrower and had a smaller angle relative to PEL 
compared to the control ponies in all three PEL regions (axial, middle, abaxial) 
of both the fore and hind feet; however, these changes were most prominent 
in the middle region (p < 0.001). In the treatment group ponies, the number 
of epidermal cell nuclei per SEL was typically higher and the number of cells 
per micrometer of SEL lower than in the control ponies. In the treatment 
group, numbers of apoptotic cells were significantly higher (p < 0.001) than in 
the control group in the abaxial and middle regions in the forefeet and hind 
feet. In addition, the numbers of proliferating cells were higher in the 
treatment group in the axial laminar regions in the forefeet and all laminar 
regions in the hind feet, versus the control group (p < 0.05).  
 
Table 1. Median (interquartile range) primary epidermal lamellar length (PELL) and width (PELW) 
in the fore and hind hooves in ponies with insulin-induced laminitis (insulin, n=4) and normal control 
ponies (control, n=4). Measurements were made in all four feet of each pony. Ten PELLs and 
PELWs per foot were measured and recorded. Statistically significant p-values (<0.05) are bolded. 
 
Fore feet 
 Control Insulin p-value 
PELL (µm) 3566 (2940-4060) 4105 (3754-4504) <0.001 
PELW (µm) 295 (263-341) 294 (249-330) N.S. 
 
Hind feet 
 Control Insulin p-value 
PELL (µm) 3267 (2929-3587) 3769 (3225-4278) <0.001 
PELW (µm) 302 (271-347) 314 (270-366) N.S. 
 
5.3 Pathology of natural cases of equine 
endocrinopathic laminitis associated with 
hyperinsulinemia (Study III) 
Lamellar morphology and pathology were described in 14 laminitic animals (4 
horses and 10 ponies) that had hyperinsulinemia (median serum basal insulin 
concentration 32.0 mIU/L, IQR 27.5–58.1 mIU/L), with reference to 25 age- 
and breed-matched controls. The median age of the laminitic animals was 15.5 
years (IQR 8.75–18.25), median BCS 4.0 (4.0–4.1) and there were 9 mares and 
5 geldings. Breeds included 5 Mixed-breed ponies, 2 Shetland ponies and one 
each of the following: Welsh section A, Russ pony, Welsh section D, Finnhorse, 
Standardbred, Irish Draft cross and Cob. Three of the hyperinsulinemic 
animals also had PPID based on elevated plasma ACTH concentration and 
clinical signs. In addition, all the laminitic animals had gross pathological 
changes (divergent rings and/or gross separation and rotation of DP) in their 
hooves (Figure 9).  
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In control animals (9 horses and 16 ponies), PEL were significantly longer 
in horses than in ponies (p < 0.001). Old horses had longer PEL than young 
horses (p = 0.04), a finding that was not seen in ponies (p = 0.99, Table 2). 
The most common PEL and SEL types, as well as PEL axial and abaxial type 
were standard, with no increase in keratinization at the abaxial aspects. 
Occasional epithelial islands were noted in axial regions in some ponies (in 3/5 
of old ponies and 2/11 of young control ponies) but these were not noted in 
horses of any age or in abaxial or middle regions in any animal. Additionally, 
the number of apoptotic cells was multifocally increased in 2/5 old ponies; up 
to 5 to 6 apoptotic cells were noted per high power field (400x). 
The histological lesions noted in laminitic animals were variable between 
individuals. The PEL were significantly longer in laminitic animals than in 
controls (p < 0.001, Table 2). Most of the lesions noticed were localized 
abaxially (close to the hoof wall) within the lamellar tissue and included 
apoptotic cell death, lamellar fusion, hyperplasia, and partial replacement 
with aberrant keratin containing nucleated debris and proteinaceous lakes. 
The lesions resulted in irregular margins between the inner horn and the 
lamellar tissue. Acute lamellar separation was seen in one-third of laminitic 
cases and it originated from the abaxial region, with minimal associated 
inflammation. In some cases, the separation was accompanied by vacuolar 
swelling of many SEL cells and marked increases in numbers of apoptotic cells. 
However, in sections where the separation was not observed, increased and 
often large numbers of apoptotic cells (up to 30 hpf) were still noted abaxially. 
 
 
Table 2. Median (interquartile range) primary epidermal lamellar length (PELL) in animals with 
naturally occurring endocrinopathic laminitis (n=14) and control animals (n=25). Measurements 
were made in the right fore foot of each animal. Ten PELLs per foot were measured and recorded. 
aSignificantly longer than in other 4 groups (p<0.05), bsignificantly longer than in young control 
horses (p<0.05). 
 
 
 
 
 
 
 
 
 
Group PELL (µm) 
Young control ponies (n=11) 2563 (2189-3368) 
Old control ponies (n=5) 2960 (2824-3456) 
Young control horses (n=4) 3039 (2793-3738) 
Old control horses  (n=5) 3837b (3384-4413) 
Animals with endocrinopathic 
laminitis (hyperinsulinemia) (n=14) 
7288a (5534-8506) 
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Axially, epidermal lamellar tapering was the most frequent morphological 
observation. Additionally, the numbers of apoptotic cells were increased in 
sections with no separation, but more variably (between horses) than in 
abaxial regions. However, the mitotic figures were most frequently observed 
in axial regions, especially in sections where separation had occurred or there 
was extensive abaxial fusion (1-3 hpf). 
 The median reported duration of laminitis (reported by the owner or 
treating veterinarian) was 120 days (range 5-730 days); however, the type and 
severity of macroscopic or microscopic lesions had no correlation with 
duration. 
5.4 Lamellar pathology in horses with pituitary pars 
intermedia dysfunction (PPID) (Study IV) 
The clinical pathology, histomorphometry and pathological lesions in lamellar 
tissue were described in PPID animals with (n=6; 4 ponies and 2 horses) or 
without (n=10; one pony and 9 horses) concurrent laminitis, with reference to 
age-matched controls (n=10; 5 ponies and 5 horses). PPID animals without 
laminitis were significantly older than control animals (median age 22 years 
vs. 16.5 years, p=0.007) and the animals with PPID and laminitis had a higher 
median BCS than the animals with PPID without laminitis (4.0 vs. 2.5, 
p<0.001). All animals with PPID and laminitis had fasting hyperinsulinaemia 
(median serum insulin concentration 74.1 mIU/L, IQR 49.9-349.5 mIU/L) 
whereas PPID animals without laminitis (and control animals) had serum 
insulin concentrations below the upper limit of the reference range (< 20 
mIU/L). In addition, all the laminitic PPID animals had macroscopic changes 
(divergent rings and/or DP deviation) in their hooves whereas the PPID 
animals without laminitis (and control animals) did not have any macroscopic 
evidence of previous episodes of laminitis.  
The lamellar morphology in nonlaminitic PPID animals was normal and 
not different from that of the control animals. Axially the most common PEL 
type was sharp whereas in control animals it was standard; however, there was 
no significant difference between the groups. 
Lamellar pathology was observed in all of the PPID animals with laminitis. 
However, alterations in lamellar morphology and pathological lesions were 
variable in severity and not related to the reported duration of laminitis 
(median 12 months, range 2 months-5 years). PEL were significantly longer 
and wider in laminitic PPID animals than in the other two groups (p<0.05). 
Most lesions were located abaxially within the lamellar tissue and included 
increased keratinization, fusion (interlamellar epidermal bridging) and 
dermoepidermal separation. Axially, increased tapering was noticed. In 2/6 
PPID animals with laminitis the number of apoptotic SEL cells was generally 
(at all levels) increased; in 2/6 they were increased only in the abaxial and 
middle regions. However, increased numbers of apoptotic cells were noticed 
also in 3/10 of the nonlaminitic PPID horses (at all levels) and 2/10 of the 
control animals (in one at all levels and in another axially). The number of 
mitotic figures in SEL cells was increased in 4/6 laminitic PPID animals, but 
they were significantly less frequent than the numbers of apoptotic cells. Most 
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of the mitotic figures were seen axially but some were noticed in other regions. 
In 2/6 laminitic PPID animals, acute separation mostly through the BM region 
was noticed in abaxial and middle regions.  
Occasional epithelial islands were noted mostly in axial regions of the PEL 
in all other groups but the control horses. However, in the control ponies the 
islands were only seen in small numbers compared to PPID animals. In PPID 
animals (both with and without laminitis), however, some islands were noted 
in addition to axial region, also in the middle and abaxial regions. 
47 
 
6 DISCUSSION 
6.1 The prevalence of endocrine diseases among 
laminitic horses 
The first aim of this thesis was to determine the prevalence of horses presented 
primarily for laminitis with a diagnosis of underlying endocrine disease (Study 
I). Endocrinopathic and pasture-associated types of laminitis have been 
known to occur commonly in field (USDA 2000, Geor 2009), yet most of the 
research has focused on laminitis arising secondary to inflammatory disease 
(Garner et al. 1975, Galey et al. 1991, Pollitt 1996, van Eps and Pollitt 2006). 
During the last few decades there has been a growing body of evidence that 
pasture-associated laminitis is also of endocrine origin. This hypothesis was 
supported in 2006 by the study of Treiber et al. where they showed that ponies 
with prelaminitic metabolic profiles (including reduced insulin sensitivity) on 
pasture in early spring (March) were 10 times more likely to have clinical 
laminitis than ponies with normal profiles in late spring (May), when the 
carbohydrate concentration in grass was high. In addition, ponies with clinical 
laminitis in late spring had significantly higher basal insulin concentrations 
than non-laminitic ponies providing more evidence of laminitis being caused 
primarily by an endocrine disease (hyperinsulinemia and/or insulin 
resistance) rather than pasture alone (Treiber et al. 2006). 
 In our study the prevalence of an underlying endocrinopathy was not just 
the majority, but almost 90%, and of those that were negative in endocrine 
tests (4/36), most had phenotypic changes typical for EMS and/or PPID. One 
previous study showed similar results: the prevalence of endocrinopathies 
among laminitic horses in a primary care setting was shown to be 70% 
(Donaldson et al. 2004). However, Donaldson’s study was published before 
EMS was well known and only animals with PPID were reported in that 70% 
figure. If laminitic animals with hyperinsulinemia with no PPID had been 
included, the prevalence would have also been approximately 90%. The results 
of this work suggest the focus of laminitis research and treatment in preceding 
decades should be now revised from inflammatory etiologies to endocrine 
laminitis. More research on prevention, treatment and management of 
endocrine laminitis and the endocrine disorders associated with it, will have 
the greatest impact on equine welfare. 
 
6.2 Diagnosis of hyperinsulinemia 
Different tests have been developed for diagnosing EMS and insulin 
dysregulation. In this dissertation, elevated basal serum insulin concentration 
was used in diagnosing hyperinsulinemia indicative of insulin dysregulation. 
This test is less sensitive for diagnosis of individual cases of insulin resistance 
than dynamic tests, such as the combined glucose-insulin tolerance test 
(CGIT; Kronfeld et al. 2005). Therefore, some of the cases of hyperinsulinemia 
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may have been missed and classified as falsely negative. In Study I there were 
4/36 horses with normal endocrine values among laminitic horses; however, 
2/4 of these had phenotypic indicators of EMS. Therefore, it may be that the 
prevalence of endocrinopathic laminitis in this study was actually even higher 
than presented. Another commonly suggested problem in insulin 
measurements is the possible effect of pain or stress induced cortisol release 
on insulin values. Cortisol has antagonist effects on insulin via its 
gluconeogenic actions and has therefore been suggested to promote insulin 
resistance and hyperinsulinemia (Johnson et al. 2004). However, when Obel 
grade ≥ 2 laminitis and colitis (moderate to severe pain) was induced 
experimentally with oligofructose overload, the horses showed only a slight 
increase in serum insulin concentration (van Eps and Pollitt 2006). In 
addition, no alteration in insulin regulation was seen in a CHO overload model 
using lower doses of oligofructose, despite alterations in glucose regulation 
(Kalck et al. 2009). It has been known from studies of humans and laboratory 
animals since the 1960’s that catecholamines associated with pain and stress 
actually inhibit insulin secretion (Porte et al. 1967). In addition, although 
acute pain or stress may increase insulin resistance at the tissue level, they 
have not been shown to affect basal insulin levels at the same time (Greisen et 
al. 2001). Therefore, it is unlikely that the increased cortisol levels due to pain 
or stress would have induced the hyperinsulinemia observed in laminitic 
animals in this thesis.  
 
6.3 Hyperinsulinemia and laminitis associated with 
PPID 
It has long been known that PPID is associated with laminitis; however, the 
exact pathogenesis of how laminitis develops in animals with PPID has not 
been explained. The results of this dissertation and previous research support 
the hypothesis that it may actually be hyperinsulinemia that is the key 
causative agent of laminitis in PPID horses. In Studies I and IV all except one 
horse with PPID and laminitis also had hyperinsulinemia. However, all the 
PPID horses without laminitis, in which insulin was measured, had normal 
insulin concentrations (3 horses in Study I, 10 horses in Study IV). In addition, 
in Study IV, all the laminitic PPID horses (with hyperinsulinemia) had 
pathological changes in the lamellar region while the lamellae of nonlaminitic 
(and normoinsulinemic) PPID horses were not different from normal aged 
horses and ponies.  
It has been suggested that insulin resistance and hyperinsulinemia may 
occur in PPID horses as a result of uncontrolled ACTH and related pituitary 
peptide release from the pituitary gland and the resultant antagonizing effects 
of cortisol on insulin. However, it is known that not all the horses with PPID 
have impairments in insulin sensitivity. In 2013, McGowan et al. showed that 
only 32% of horses with a diagnosis of PPID (using basal ACTH) had 
hyperinsulinemia (McGowan et al. 2013). Later, Mastro et al. showed that 
there was no difference in insulin sensitivity between old horses with PPID 
and old control horses (Mastro et al. 2015). Therefore, it may be suggested that 
49 
 
PPID alone may not cause the insulin insensitivity in those PPID animals with 
hyperinsulinemia. In addition, if hyperinsulinemia does occur due to PPID 
related hormone release, it could be assumed that the PPID horses without 
clinical laminitis would have had at least early or mild histological changes in 
their lamellar region, which they did not have. In addition, usually horses with 
PPID have resting cortisol concentrations within the reference range, which 
does not support the aforementioned theory either (Hillyer et al. 1994, Couëtil 
et al. 1996, Eiler et al. 1997, van der Kolk 1998, Reynolds and Walker 2003). 
It is possible that all PPID animals with laminitis have also either 
subclinical or clinical EMS. The prevalence of PPID in horses ≥ 15 years old 
has been shown to be 21% (McGowan et al. 2013) and the prevalence of 
hyperinsulinemia as an indicator of EMS (in a population where PPID animals 
have been excluded) in ponies (mean age 9 years) was 27% in Australia 
(Morgan et al. 2014). In addition, age has been shown to be a significant risk 
factor for hyperinsulinemia (Morgan et al. 2014). Therefore, the probability of 
having PPID and EMS together in the same animal may be considered quite 
high, especially in older horses (≥ 15 yrs.). It may be that the pituitary peptides 
released in PPID exacerbate underlying insulin resistance in horses with EMS, 
allowing for the clinical expression of laminitis and PPID. Therefore, it is 
possible that in animals with subclinical EMS, the development of PPID later 
in life makes them more insulin resistant and more susceptible to laminitis.  
 
6.4 Epidermal cellular changes in insulin-induced 
laminitis 
The second article of this dissertation (Study II) supported the hypothesis that 
the histology of insulin-induced laminitis is different from that in the 
previously described inflammatory laminitis. Increased inflammation 
(defined as increased leukocyte infiltration), metalloprotease activity and BM 
degradation have been shown to have role in the development of inflammatory 
laminitis modeled with CHO overload or BWE (Pollitt 1996, Kyaw-Tanner and 
Pollitt 2004, Black et al. 2006, Loftus et al. 2006, Kyaw-Tanner et al. 2008, 
Faleiros et al. 2011a, Faleiros et al. 2011b). BWE studies have shown that 
leukocyte infiltration is a key element in the development of laminitis lesion, 
but in CHO overload studies the leukocytes have been shown to arrive only 
after the tissue (BM) pathology is underway (Visser 2008, Faleiros et al. 2009, 
Faleiros et al. 2011a). In studies on insulin-induced laminitis (including this 
dissertation), leukocytes have not been shown to increase significantly 
compared to controls and the minor extravasation noticed has been shown to 
follow (similar to CHO overload models) the development of BM lesions and 
alterations in SEL architecture (Asplin et al. 2010, de Laat et al. 2011a, de Laat 
et al. 2011b). Therefore, it is unlikely that leukocytes would initiate the 
lamellar epithelial damage in CHO overload or insulin models. Interestingly, 
the extent and severity of inflammation in both CHO overload and insulin 
models (but not in BWE models) are significantly less than would be expected 
in many other tissues subjected to similar levels of cellular stress and 
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mechanical compromise, including the skin. However, the reason for this 
finding is not known. 
BM separation (possibly related to increased metalloprotease activity) has 
been suggested to be a key element in inflammatory laminitis (Pollitt 1996). 
However, in hyperinsulinemia models, as well as in this dissertation, BM 
lesions have been absent to limited and have followed SEL elongation and 
cellular degradation (Asplin et al. 2010, de Laat et al. 2011a, Study II). These 
findings indicate a spectrum of severity of BM separation in insulin-induced 
laminitis that occurs after the SEL elongation phase and cellular damage. 
Another important point is that in ponies with insulin-induced laminitis 
(Study II), the BM damage appeared to occur mostly axially, whereas in 
animals with naturally occurring endocrinopathic laminitis (Study III) the 
separation occurred abaxially, indicating that the BM lesion hypothesis cannot 
fully explain the lesions occurring naturally.  
Even though increased leukocyte infiltration, metalloprotease activity and 
BM separation do not seem to be key elements of insulin-induced laminitis, 
increased numbers of apoptotic cells and autophagocytosis were noticed in the 
hyperinsulinemic ponies in Study II 50 h after the onset of pEHC. Therefore, 
it is possible that inflammatory events also occur in hyperinsulinemic 
laminitis, but within the epithelium itself, not from the infiltration of 
leukocytes. Apoptotic cells were rare in normal lamellar tissue, but 
significantly increased in the abaxial and middle regions of PEL in all 4 feet of 
the hyperinsulinemic ponies, indicating some form of cytokine signaling 
resulting in the dramatic cellular response in those regions. 
The numbers of proliferating cells (confirmed by TPX2 immunolabeling) 
were also significantly increased in ponies with hyperinsulinemic laminitis at 
50 h: only axially in their fore feet but in all regions in their hind feet. In one 
previous study it was hypothesized that aberrant proliferation of lamellar 
epidermal cells, potentially due to alterations in cell signaling and a 
predominance of insulin-like growth factor 1 (IGF1) or MAPK pathways which 
favor mitogenesis and growth, might be the key lesion of insulin-induced 
laminitis causing SEL elongation (de Laat et al. 2013a, de Laat et al. 2013b). 
However, in Study II, after measuring the length of SELs, we found a reduction 
of epidermal SEL cells per micrometer, despite elongation of the SEL in ponies 
with insulin-induced laminitis, and concluded that elongation was probably 
secondary to cell degradation/damage and loss of structural integrity under 
the biomechanical forces of weight bearing, rather than aberrant proliferation. 
Additionally, epidermal cell proliferation has not been shown to be an 
important element in naturally occurring laminitis either: In one previous 
study the lamellae of animals with naturally occurring laminitis (even though 
different etiologies) had reduced amounts of epidermal stem cells suggesting 
rather decreased than increased proliferation capacity (Carter et al. 2011). 
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6.5 The histology of naturally occurring 
endocrinopathic laminitis 
Even though the histology of experimentally induced hyperinsulinemic 
laminitis has been well described (Asplin et al. 2010, de Laat et al. 2011a, de 
Laat et al. 2012a, de Laat et al. 2013a, Study II), the experimental models only 
show us the effect of  hyperinsulinemia and indicate what structures alter in 
response in the acute phase. Naturally occurring endocrinopathic laminitis is 
seldom, if ever acute, but develops gradually with time. Therefore, not all the 
experimental models represent the naturally occurring endocrinopathic 
laminitis very well.  
The normal histology and morphometry of lamellar tissue had not been 
properly described previously and therefore it may have been challenging to 
differentiate pathological lesions from normal ones. For this reason, in Studies 
III and IV we described the histology and histomorphometry of the lamellar 
regions of young and old, clinically healthy animals with no evidence of 
endocrinopathic disease. Recently the histology of the lamellar region has 
been described in animals without clinical or history of clinical laminitis 
(Kawasako et al. 2009). However, these animals were not healthy otherwise 
but were euthanized because of some other disease (e.g. infection, colic, bone 
fracture) and may, therefore, have had conditions that predispose to 
subclinical or early (in this case either inflammatory or mechanical) laminitis. 
The predominance of tapered SEL type abaxially and detection of hyperplastic 
changes in the aforementioned study are findings that we did not observe in 
our healthy control animals and they may be considered as possible laminitis 
lesions. In addition, in Kawasako’s study also foals (1-9 months old, n=9/35) 
and yearlings (n=5/35) were included whereas we included only animals that 
were over one-year-old. The morphology of the lamellar region has been 
shown to change during the first year of life and therefore only animals of a 
similar age can be compared with each other (Bidwell and Bowker 2006). It is 
also likely that the weight of the animal as well as the mechanical environment 
affect the lamellar morphology, but as far as the author is aware, no proper 
research on this has been published. Kawasako et al. (2009) suggested that 
the dominant PEL type would depend on the mechanical stimulation. Only in 
the racehorse group in their study was the predominant PEL type standard 
(straight) and in the other groups it was curving. However, in our study the 
most common PEL type was standard in all the control groups. Therefore, it is 
likely, that also other factors than the mechanical environment affect the PEL 
type. Interestingly, the most common axial PEL type in Kawasako’s oldest 
group (mares 7 to 22 years) was sharp. In our studies old horses (old control 
horses in Study III and PPID horses without laminitis in Study IV) seemed to 
have more sharp axial PEL ends than animals in other groups although no 
statistical significance was found. In addition, old control horses in Study III 
had significantly longer PEL than young control horses. However, whether the 
PEL elongation or sharpness of PEL axial end is related to aging, warrants 
more research.  
The third article (Study III) was the first to describe the histology of 
naturally occurring endocrinopathic laminitis. We hypothesized that the 
lamellar histology of naturally occurring cases would resemble that of horses 
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and ponies with experimentally induced hyperinsulinemic laminitis, but show 
more advanced lesions based on chronicity. The hypothesis was shown to be 
correct with lamellar elongation, altered SEL angles and cellular changes with 
limited to no inflammation and lack of widespread BM degradation. A new 
finding was that the microscopic lesions in laminitic animals were largely 
localized abaxially (close to the hoof wall) in most cases; however, the cellular 
changes including apoptosis and mitosis were noticed also axially (although 
less than abaxially). The abaxial lesions included apoptotic cell death, as well 
as lamellar fusion, hyperplasia, and partial replacement with aberrant keratin 
containing nucleated debris and proteinaceous lakes. These changes could be 
interpreted as representing the following sequence of events: 1. fusion of the 
tips of SELs across the PDL resulting in isolation of rounded areas of vascular 
dermal tissue that continued to keratinize peripherally (centrifugally) and 
produce increasing amounts of cap horn (Figure 10); 2. reduction in the area 
of this dermal ‘circle’ with complete isolation from the more axial (epidermal 
and dermal) tissue by keratin, and keratinization of most of the immediately 
surrounding epidermal tissue (Figure 11); 3. degeneration of the blood 
vessel(s) and completion of keratinization of the remaining (central) 
epidermal cells (Figure 12); and finally, 4. filling of the area with keratin or 
proteinaceous fluid (Figure 13). The aforementioned lesions would all in 
theory, predispose the lamellar tissue to tearing. When tearing was seen 
histologically in Study III, it was always abaxial and involved BM separation, 
tearing of SELs, and/or separation of the PEL by ripping through the SEL 
bases - in acute inflammatory cases (induction models) tearing has been 
shown to be mostly axial and involving exclusively BM separation (Pollitt 
1996, de Laat et al. 2011a). In cases of naturally occurring endocrinopathic 
laminitis, we observed leukocytes, although surprisingly minimal, mostly 
related to epidermal-dermal separation and consider that to be a normal 
reaction (secondary) after tissue damage. 
The reason why lesions in these chronic natural cases are mostly located 
in the abaxial region is unknown but there are a few suggested theories 
including hypocirculation due to longer distance from the primary vascular 
supply of the dermis, higher metabolic rates or susceptibility to toxins (e.g. 
insulin) or greater mechanical stress in abaxial epidermal cells vs. axial cells 
(Morgan et al. 2003, Study II). Another hypothesis is that the lesions start 
axially from the origin of the blood supply that delivered factors inciting the 
lamellar cell damage and then extend abaxially. Therefore, in a naturally 
affected animal with typically chronic lesions, as opposed to (acute) 
experimental cases, these lesions will be more likely to be observed abaxially.   
However, more research with better and humane models of the disease is 
warranted to fully document the temporal changes in naturally occurring 
laminitis. 
Epithelial islands (often completely unconnected to their respective PEL) 
have been described previously in horses with naturally occurring chronic 
laminitis (‘keratin pearls’, Roberts et al. 1980), and also in experimental 
animals seven days post-induction of laminitis with oligofructose (i.e. 
inflammatory laminitis; van Eps & Pollitt 2009). In Studies III and IV, 
epithelial islands were commonly observed mostly axially in laminitic animals; 
however, occasional axial small epithelial islands were also noted in some 
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control ponies but not in control horses. This relatively frequent occurrence of 
axial epithelial islands in pony hooves, perhaps represents subclinical damage 
(‘normal wear and tear’) caused by some factors not directly related to 
laminitis (e.g. mechanical overloading) clearly not experienced in horse 
hooves. In some laminitic animals the epithelial islands were not confined to 
axial regions (i.e. adjacent to PEL tips) - they were also seen in middle and 
abaxial regions of the lamellar tissue. This might be directly related to 
laminitis pathophysiology as previously noted in models of inflammatory 
laminitis, however the extent of island formation was extreme in that model 
and not necessarily comparable (van Eps and Pollitt 2009). It could also 
represent a spatial shifting of mechanical forces (that exceed SEL ‘safety 
limits’) within the damaged hoof wall. Interestingly this expansion of the area 
affected by island formation was also seen in some PPID horses that did not 
have laminitis, perhaps again indicating a change in hoof wall dynamics not 
directly associated with hyperinsulinemia or with noticeable lameness. 
 
6.6 Macroscopic changes of the hoof in naturally 
occurring endocrinopathic laminitis 
Macroscopic structural changes of the hoof wall, like divergent rings, have 
been previously anecdotally known as indicative of chronic laminitis. 
However, Study III is the first to document macroscopic changes (either 
divergent rings and/or ventral DP deviation) corresponding with the histology 
in (all) clinical cases of naturally occurring laminitis. The exact mechanism of 
divergent ring formation and why they are divergent (wider at the heels than 
the toe) is not known. A healthy hoof grows faster from the dorsal part than 
from the heels, but in laminitis this growth pattern no longer applies. It may 
be that the cellular changes (e.g. stretching and apoptosis) in the laminitic hoof 
are worse on the dorsal part of the hoof wall than in the heels and therefore 
growth is compromised more severely there. Another explanation might be 
that the blood supply to the dorsal hoof wall is reduced or that altered 
biomechanical forces occurring along the dorsal hoof wall allow greater 
elongation of the PELs and SELs there relative to the heels. Only dorsal hoof 
wall samples were obtained in this dissertation; however, sampling would be 
required also from other parts of the hoof wall to better understand the 
mechanism behind the divergent ring formation.  
The severity of both macroscopic and microscopic lesions was not 
correlated with the reported duration of clinical lameness due to laminitis. 
Many animals (6/14) had divergent rings in their hooves but a reported 
duration of laminitis shorter than the rings would need to form (<3 months). 
Therefore, it may be suggested that clinical laminitis was preceded by a 
prolonged subclinical phase. Additionally, it may also be suggested that if the 
divergent rings are noted before the clinical signs, laminitis may be possible to 
prevent e.g. by changing the diet and lifestyle to reduce the hyperinsulinemia. 
In another study from Australia all ponies with a history of laminitis also had 
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divergent rings, but there were also some animals (ponies) with divergent 
rings without an owner-reported history of laminitis (Morgan et al. 2014); 
therefore, it is possible that a long phase of preclinical laminitis is common. 
However, the rate at which natural endocrinopathic lamellar pathology occurs 
in subclinical episodes ahead of the acute episode is not known. Due to the 
chronic nature of endocrine disease development, it is possible that many 
animals with endocrinopathic laminitis suffer from repeated episodes of 
lamellar alteration before clinical signs are noted. However, it is also likely that 
there is significant individual variation in the severity and frequency of these 
subclinical episodes where factors like weight, mechanical environment, hoof 
shape and duration of hyperinsulinemia may have an effect on the 
development of hoof capsular changes. 
 
6.7 Treatment and prevention of endocrinopathic 
laminitis 
Despite a large amount of research, the mechanism by which 
hyperinsulinemia causes laminitis is still only partly understood. As far as the 
treatment options are concerned, a deeper understanding of the actions of 
insulin and disease pathogenesis would be required. However, one possible 
mechanism that has been suggested is an insulin-induced imbalance between 
ET-1 and nitric oxide, leading to over-expression of ET-1 and vasoconstriction, 
which has been shown to occur in humans and rodents (Kim et al. 2006). 
Interestingly, short-term hyperinsulinemia was recently shown to cause 
increased vascular resistance and ET-1 expression in equine cadaver limbs 
(Gauff et al. 2013). Later the same group showed that hyperinsulinemia causes 
significant changes in endothelin receptor (ETR) expression in equine limbs 
and suggested that ETR antagonists might be beneficial in the treatment of 
laminitis (Gauff et al. 2014).  However, the use of ETR antagonists in the 
treatment or hyperinsulinemic laminitis requires further investigation in vivo. 
Based on findings of other studies and this dissertation, veterinarians are 
recommended to concentrate on preventive measures for the development of 
hyperinsulinemia; especially the identification, prevention and treatment of 
the endocrine dysfunction. In many cases with endocrinopathic laminitis 
tissue damage in the lamellar region appears to be well under way before the 
onset of clinical signs and therefore early diagnosis and treatment of endocrine 
diseases is of crucial importance. Horses with obesity (either general or 
regional), delayed hair shedding or long hair coats should be tested for an 
endocrine disorder, especially hyperinsulinemia. In addition, observations for 
changes in the hoof wall should be included in veterinary check-ups and if 
divergent rings or cap horn are noticed that should prompt endocrine 
evaluation. Anti-inflammatory agents like cyclooxygenase (COX) inhibitors 
have been traditionally used for the treatment of laminitis; however, more 
55 
 
work on the most appropriate anti-inflammatory is warranted. Based on our 
results, treatment of inflammation in the classic sense is not necessary in cases 
of endocrinopathic laminitis, but the vascular effects of non-steroidal anti-
inflammatory agents (NSAIDs) may well be warranted. More COX-2 selective 
anti-inflammatory drugs have become popular recently, but COX-2 has been 
shown to be constitutive in the hoof lamellae and therefore COX-2 selective 
drugs may not be ideal (Blikslager et al. 2006).  It is clear, however, that if 
prevention is not achieved, effective analgesia and biomechanical support of 
the hooves would be advisable. 
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7 FUTURE PERSPECTIVES 
Studies III and IV of this dissertation are first to describe the histopathology 
of naturally occurring endocrinopathic (hyperinsulinemia with or without 
PPID) laminitis and compare the histology with healthy animals. Since the 
sample sizes were relatively small, more samples would be beneficial in future 
to strengthen the results and conclusions of this dissertation. In addition to 
the traditional dorsal hoof wall samples, lamellar samples should be collected 
also from other parts of the hoof. The normal hoof growth differs in different 
parts of the foot and samples collected around the hoof wall might give us more 
information of the cellular events associated with e.g. divergent ring 
formation. 
We also described the normal histology of lamellar region in this 
dissertation. However, the control animals were mostly pleasure horses from 
Europe (Finland or UK) and therefore the use and mechanical environment 
the horses were living in were quite similar. The future work could compare 
the normal histology of animals that are used for racing purposes (in which 
the mechanical stimulation of the lamellar region is much more severe than in 
pleasure animals) and that of the pleasure animals to find out the effect of 
mechanical stress in the lamellar region. Kawasako et al. (2009) suggested 
that certain PEL types might be more common in racehorses compared to 
pleasure animals (Kawasako et al. 2009), but more research regarding the 
normal morphological variation is warranted. In addition, different 
environments may influence the lamellar morphology and therefore also 
samples from horses kept on harder and drier surfaces (compared to Finland 
and UK) might increase our knowledge of morphological variation. 
The lamellar samples of this dissertation were collected from dead 
animals. Ideally, the development of protocols for minimally-invasive 
techniques to collect biopsies from live horses with endocrinopathic laminitis 
would help in the prognosis of horses. Morgan et al. (2003) collected lamellar 
samples by drilling a hole through the dorsal hoof wall and then removed 
lamellar tissue with scalpel blades and biopsy knives (Morgan et al. 2003). 
However, this procedure is highly invasive and potentially harmful for the 
horse, although all the biopsied horses in Morgan’s study recovered 
completely and did not have any adverse effects attributable to the biopsy 
procedure. Since lamellar tissue may be considered histologically as highly 
specified skin, it is possible that hyperinsulinemia affects also other epithelial 
structures. In horses with endocrinopathic laminitis e.g. skin. These tissues 
might show changes during hyperinsulinemia and offer some clues about the 
possible lesions in lamellae. In addition, the aforementioned sites would be 
much easier and safer to biopsy than the hoof. 
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